Therapeutic implications of menin inhibition in acute leukemias
Descrição
Therapeutic implications of menin inhibition in acute leukemias
Co-inhibition of HDAC and MLL-menin interaction targets MLL
Pharmacologic Inhibition of the Menin-MLL Interaction Blocks
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant
Contemporary Approach to Acute Myeloid Leukemia Therapy in 2022
Novel Therapies Targeting Menin for Relapsed or Refractory Acute
The clinical impact of the molecular landscape of acute myeloid
Pipeline - Biomea Fusion
Full article: Emerging small molecular inhibitors as targeted
Cancers, Free Full-Text
Effective Menin inhibitor-based combinations against AML with MLL
Frontiers Roles of Histone Deacetylases in Acute Myeloid
The Menin/KMT2A interaction is a therapeutic target in human MN1
Current status and future perspectives in targeted therapy of NPM1
A molecular switch between mammalian MLL complexes dictates
de
por adulto (o preço varia de acordo com o tamanho do grupo)
/i.s3.glbimg.com/v1/AUTH_bc8228b6673f488aa253bbcb03c80ec5/internal_photos/bs/2023/u/B/EzMlQPSAuMhzGwhetVDQ/sindel-mortal-kombat-1-kitana-liu-kang.jpg)
